Sam Hulsey is an associate in Weil’s Mergers & Acquisitions practice and is based in New York. Mr. Hulsey participates in the representation of public and private companies in mergers, acquisitions and divestitures.
Mr. Hulsey has participated in advising:
- athenahealth, Inc. in its $5.7 billion sale to Veritas Capital and Evergreen Coast Capital (an affiliate of Elliott Management Corporation) and planned combination with Virence Health
- Carlin America, Inc. in its $245 million sale to Round Hill Music, LLC
- Dow Inc. in its approximately $40 billion spin-off from DowDuPont Inc. as part of DowDuPont's separation into three independent, publicly traded companies
- Eli Lilly and Company in its $1.1 billion acquisition of Dermira, Inc.
- Fogo de Chão Churrascaria (Holdings), LLC (a publicly traded company backed by Thomas H. Lee Partners) in its $560 million take-private sale to Rhône Capital
- General Electric Company in its $2.6 billion sale of GE Industrial Solutions
- The Kroger Company in the $2.15 billion sale of its convenience store business unit to EG Group
- Ontario Teachers' Pension Plan in the sale of its stake in Cole-Parmer Instrument Company (C-P) to GTCR in connection with a $2.1 billion recapitalization of C-P led by GTCR in which Golden Gate Capital and C-P management retained minority stakes
- Quest Diagnostics Inc. in its acquisition of the U.S. laboratory services business of Oxford Immunotec Global PLC
- Sanofi in its $11.6 billion acquisition of Bioverativ Inc. and in its $350 million sale of its Seprafilm Adhesion Barrier and related assets to Baxter International Inc.
Mr. Hulsey received his J.D. from New York University School of Law and his B.A. from USC (Southern California).